Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.012 mg/ML [Ixiaro]
RxNorm 1300782
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1300782 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.012 mg/ML [Ixiaro].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDCPrescribable
Semantic Branded Drug Component (SBDC):
Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.012 mg/ML [Ixiaro]
(Atom ID: 4626261)
Patient Education
Japanese Encephalitis Vaccine
What is Japanese encephalitis? Japanese encephalitis (JE) is a serious infection caused by the Japanese encephalitis virus. It occurs mainly in rural parts of Asia. It is spread through the bite of an infected mosquito. It does not spread from person to person. Risk is very low for most travelers. It is higher for people living in areas where the disease is common, or for people traveling there for long periods of time. Most people infected with JE virus don't have any symptoms. Others might have symptoms as mild as a fever and headache, or as serious as encephalitis (brain infection). A person with encephalitis can experience fever, neck stiffness, seizures, and coma. About 1 person in 4 with encephalitis dies. Up to half of those who don't die have permanent disability. It is believed that infection in a pregnant woman could harm her unborn baby. JE vaccine can help protect travelers from JE disease.
[Learn More]
* Please review the disclaimer below.
